Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.620
-0.180 (-6.43%)
Oct 17, 2025, 4:16 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.35 billion as of October 17, 2025. Its market cap has increased by 117.66% in one year.
Market Cap
3.35B
Enterprise Value
3.30B
Revenue
26.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.62
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.35B, an increase of 4,279.67%. That is a compound annual growth rate of 19.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 3.35B | -5.63% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | 1.32B | 19.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 105.61B |
| Pro Medicus | 29.85B |
| Cochlear | 18.68B |
| Sonic Healthcare | 10.71B |
| Ramsay Health Care | 7.27B |
| Telix Pharmaceuticals | 5.63B |
| Ansell | 4.82B |
| Neuren Pharmaceuticals | 2.61B |